Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.14%
1,102.18
+1.57
+0.14%
—1,100.611,106.151,114.281,098.89——
SIXC
Communications
SIXC
Communications
SIXC
+0.64%
616.24
+3.94
+0.64%
—612.30612.30616.40612.30——
SIXE
Energy
SIXE
Energy
SIXE
+1.21%
1,189.72
+14.26
+1.21%
—1,175.461,182.971,193.951,182.97——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,725.69
-3.43
-0.20%
—1,729.121,731.371,754.071,718.58——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
643.62
-1.11
-0.17%
—644.73645.31649.16642.15——
SIXR
Staples
SIXR
Staples
SIXR
+0.33%
829.79
+2.70
+0.33%
—827.09828.05833.90827.27——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.66%
213.40
-1.42
-0.66%
—214.82214.82216.61212.62——
SIXT
Technology
SIXT
Technology
SIXT
+2.27%
3,185.92
+70.75
+2.27%
—3,115.173,142.773,186.203,133.07——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.16%
908.94
-1.49
-0.16%
—910.43915.18923.94906.03——
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,478.96
+4.46
+0.30%
—1,474.501,480.841,491.461,475.55——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.02%
2,405.36
-0.51
-0.02%
—2,405.872,415.572,420.792,398.99——
MRK:NYSE
Merck & Co Inc
$112.89
+0.29%
(+0.33) 1D
$112.80
-0.08% (-0.090)
After hours
Closed: Apr 22, 4:01:13 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
Open
$112.60
High
$113.51
Low
$111.54
Mkt. cap
278.82B
Avg. vol.
9.81M
Volume
0.00
Dividend
3.01%
Quarterly dividend
$0.85
Ex dividend date
Mar 16, 2026
P/E ratio
15.50
52-wk high
$125.14
52-wk low
$73.31
EPS
$7.28
Beta
0.27
Shares outstanding
2.47B
No. of employees
74K
News stories
From sources across the web
Profile
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEORobert M Davis
Employees74K
FoundedJan 1, 1891
Headquarters-
SectorPharmaceutical industry
Websitemerck.com
Next call in 7 days
Thu, Apr 30, 9:00 AM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-1.47 est.)USD
Revenue / Estimate
-/ (15.84B est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
15.53B
15.81B
17.28B
16.40B
Cost of goods sold
3.38B
3.39B
3.74B
4.30B
Cost of revenue
3.38B
3.39B
3.74B
4.30B
Research and development expenses
3.52B
4.00B
4.00B
4.00B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.40B
2.50B
2.48B
2.73B
Operating expense
5.92B
6.49B
6.48B
6.73B
Total operating expenses
9.31B
9.88B
10.23B
11.02B
Operating income
6.22B
5.92B
7.05B
5.38B
Other non operating income
91.00M
69.00M
-
41.00M
EBT including unusual items
5.90B
5.00B
6.74B
3.42B
EBT excluding unusual items
6.02B
5.68B
6.76B
4.98B
Income tax expense
818.00M
571.00M
958.00M
458.00M
Effective tax rate
13.86%
11.42%
14.20%
13.39%
Other operating expenses
-
-
-
-
Net income
5.08B
4.43B
5.78B
2.96B
Net profit margin
32.71%
28.01%
33.49%
18.07%
Earnings per share
2.22
2.13
2.58
2.04
Interest and investment income
109.00M
69.00M
96.00M
69.00M
Interest expense
-313.00M
-305.00M
-327.00M
-411.00M
Net interest expenses
-204.00M
-236.00M
-231.00M
-342.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.28B
6.99B
8.15B
6.79B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer